Surgery Partners, Inc. declines Bain Capital's $25.75/share offer, citing growth potential. Click for my updated look at SGRY ...

Discover why Arbor Realty Trust stands out as a contrarian buy with strong recovery potential, a 12% yield, and robust risk ...

The Fed Chair Powell stated during the press conference following the June meeting that there is "a meaningful inflation ...

Explore Qualys' strong niche in exposure management, robust financials, and conservative strategy amidst rising competition ...

UnitedHealth's selloff is partly a market overreaction to temporary Medicare Advantage headwinds. Read why investors should ...

S&P 500 trades above 10x price-to-sales, surpassing dot-com levels. We discuss charts that contrast the future profit growth optimism with the reality of economic conditions.

Innoviz Technologies Ltd. secured a major OEM deal, leading in Lidar's growth race. Click for why INVZ is a high-risk, ...

Oscar Health is uniquely undervalued, combining 42% revenue growth with profitability and a low EV/Sales multiple. Click here ...

Quantum Computing hype? Learn why experts predict a 90% stock drop, highlighting red flags like minimal revenue and high ...

The SPDR® S&P Global Dividend ETF for diversified global dividend income. Click for how WDIV complements US dividend ...

Sanofi acquires Blueprint Medicines Corporation for $9.1bn, gaining revenue-driving Aykavit and pipeline drug BLU-808 ...

Northern Dynasty received the third $12 million tranche investment under its royalty agreement. Click here to find out why ...